{"id":62430,"date":"2026-01-01T19:02:26","date_gmt":"2026-01-01T18:02:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/"},"modified":"2026-01-01T19:02:26","modified_gmt":"2026-01-01T18:02:26","slug":"atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/","title":{"rendered":"AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5637104\/atricure-inc-atrc-product-pipeline-analysis?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=8jt5k2&amp;utm_campaign=2125097+-+AtriCure+Inc+(ATRC)+Product+Pipeline+Analysis+Report+2025%3A+Portfolio+Led+by+Isolator+Synergy%2C+AtriClip%2C+Hybrid+AF+Therapy%2C+and+cryoICE+cryoSPHERE+Technologies&amp;utm_exec=chdomspi\" rel=\"nofollow\" shape=\"rect\">&#8220;AtriCure Inc (ATRC) &#8211; Product Pipeline Analysis, 2025 Update&#8221;<\/a> company profile has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251231905966\/en\/2680151\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251231905966\/en\/2680151\/22\/logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251231905966\/en\/2680151\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251231905966\/en\/2680151\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report is a source for data, analysis, and actionable intelligence on the company&#8217;s portfolio of pipeline products. The report provides key information about the company, its major products and brands.<\/p>\n<p>\nAtriCure Inc (AtriCure) is a company specialising in the development and provision of medical technologies for the treatment of atrial fibrillation (Afib) and related conditions. The company&#8217;s primary activities involve the development and distribution of medical devices used by electrophysiologists and cardiothoracic surgeons. AtriCure&#8217;s major products include the Isolator Synergy ablation system, AtriClip left atrial appendage exclusion system, hybrid AF therapy, and cryoICE cryoSPHERE probe.<\/p>\n<p>\nThese products are used in various surgical procedures, including open-heart and minimally invasive surgeries, to treat Afib and manage post-operative pain. The company markets its products through various brands such as AtriCure, Coolrail, Isolator, Synergy, Flex-V, Lariat, Hybrid AF, cryosphere, cryoICE, AtriClip, COBRA, COBRA Fusion, Affirm, and EPi-Sense. It operates in the US, Germany, France, the UK, the Benelux region, Canada, and Australia, among other locations. AtriCure Inc is headquartered in Mason, Ohio, the US.<\/p>\n<p>\nThe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.<\/p>\n<p>\n<strong>Reasons to Buy:<\/strong><\/p>\n<ul>\n<li>\nDevelop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape<\/li>\n<li>\nDesign and develop your product development, marketing and sales strategies by understanding the competitor portfolio<\/li>\n<li>\nTo formulate effective Research &amp; Development strategies<\/li>\n<li>\nDevelop market-entry and market expansion strategies<\/li>\n<li>\nExploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return<\/li>\n<li>\nPlan mergers and acquisitions effectively by identifying key players of the most promising pipeline<\/li>\n<li>\nIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage<\/li>\n<li>\nDevelop competition strategies by identifying the status and likely launch of the competitors&#8217; pipeline products through review of the clinical trials, stage and of development, etc<\/li>\n<li>\nIdentify, understand and capitalize the next high-value products that your competitor would add in its portfolio<\/li>\n<\/ul>\n<p>\n<strong>AtriCure Inc, Recent Developments<\/strong><\/p>\n<ul>\n<li>\nDec 11, 2025: AtriCure Announces the First Patients Treated with Novel Dual Energy Platform<\/li>\n<li>\nNov 18, 2025: AtriCure to Participate in Piper Sandler 37th Annual Healthcare Conference<\/li>\n<li>\nOct 29, 2025: AtriCure treats first subject in BoxX-NoAF study<\/li>\n<li>\nOct 28, 2025: AtriCure Announces First Patient Treated in BoxX-NoAF Clinical Trial<\/li>\n<li>\nOct 27, 2025: AtriCure to Participate in Upcoming Investor Conferences<\/li>\n<li>\nOct 08, 2025: AtriCure To Announce Third Quarter Financial Results<\/li>\n<li>\nAug 20, 2025: AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference<\/li>\n<li>\nAug 04, 2025: AtriCure Receives Additional FDA 510(K) Clearance for Isolator Synergy Encompass Clamp<\/li>\n<li>\nJul 28, 2025: AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference<\/li>\n<li>\nJul 15, 2025: AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong><\/p>\n<ul>\n<li>\nAtriCure Inc Company Overview<\/li>\n<li>\nAtriCure Inc Company Snapshot<\/li>\n<li>\nAtriCure Inc Pipeline Products and Ongoing Clinical Trials Overview<\/li>\n<li>\nAtriCure Inc &#8211; Pipeline Analysis Overview<\/li>\n<li>\nBusiness Description<\/li>\n<li>\nAtriCure Inc &#8211; Key Facts<\/li>\n<li>\nAtriCure Inc &#8211; Major Products and Services<\/li>\n<li>\nAtriCure Inc Pipeline Products by Development Stage<\/li>\n<li>\nAtriCure Inc Ongoing Clinical Trials by Trial Status<\/li>\n<li>\nAtriCure Inc Pipeline Products Overview<\/li>\n<li>\nAtriClip System &#8211; Stroke<\/li>\n<li>\nAtriClip System &#8211; Stroke Product Overview<\/li>\n<li>\nAtriClip System &#8211; Stroke Clinical Trial<\/li>\n<li>\nAtriCure Isolator Synergy Surgical Ablation System &#8211; Inappropriate Sinus Tachycardia (IST)<\/li>\n<li>\nAtriCure Isolator Synergy Surgical Ablation System &#8211; Inappropriate Sinus Tachycardia (IST) Product Overview<\/li>\n<li>\nCryoICE Ablation System &#8211; Atrial Fibrillation<\/li>\n<li>\nCryoICE Ablation System &#8211; Atrial Fibrillation Product Overview<\/li>\n<li>\nCryoICE Ablation System &#8211; Atrial Fibrillation Clinical Trial<\/li>\n<li>\ncryoSPHERE Cryoablation Probe &#8211; Sternotomy<\/li>\n<li>\ncryoSPHERE Cryoablation Probe &#8211; Sternotomy Product Overview<\/li>\n<li>\nLARIAT Suture Delivery Device &#8211; Adjunctive Therapy<\/li>\n<li>\nLARIAT Suture Delivery Device &#8211; Adjunctive Therapy Product Overview<\/li>\n<li>\nNext Generation RF Generator<\/li>\n<li>\nNext Generation RF Generator Product Overview<\/li>\n<li>\nPFA Clamp<\/li>\n<li>\nPFA Clamp Product Overview<\/li>\n<li>\nAtriCure Inc &#8211; Key Competitors<\/li>\n<li>\nAtriCure Inc &#8211; Key Employees<\/li>\n<li>\nAtriCure Inc &#8211; Key Employee Biographies<\/li>\n<li>\nAtriCure Inc &#8211; Locations And Subsidiaries<\/li>\n<li>\nHead Office<\/li>\n<li>\nOther Locations &amp; Subsidiaries<\/li>\n<li>\nRecent Developments<\/li>\n<li>\nAppendix<\/li>\n<\/ul>\n<p>\nFor more information about this company profile visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5637104\/atricure-inc-atrc-product-pipeline-analysis?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=8jt5k2&amp;utm_campaign=2125097+-+AtriCure+Inc+(ATRC)+Product+Pipeline+Analysis+Report+2025%3A+Portfolio+Led+by+Isolator+Synergy%2C+AtriClip%2C+Hybrid+AF+Therapy%2C+and+cryoICE+cryoSPHERE+Technologies&amp;utm_exec=chdomspi\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/2idcyc<\/a><\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong><\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;p&#114;&#x65;&#115;&#x73;&#64;&#114;&#x65;s&#x65;a&#114;&#x63;h&#x61;&#x6e;&#100;&#x6d;a&#114;&#x6b;&#101;&#x74;s&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#115;&#64;res&#x65;&#x61;&#x72;&#x63;&#104;&#97;ndm&#x61;&#x72;&#x6b;&#x65;&#116;&#115;&#46;co&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;AtriCure Inc (ATRC) &#8211; Product Pipeline Analysis, 2025 Update&#8221; company profile has been added to ResearchAndMarkets.com&#8217;s offering. This report is a source for data, analysis, and actionable intelligence on the company&#8217;s portfolio of pipeline products. The report provides key information about the company, its major products and brands. AtriCure Inc (AtriCure) is a &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62430","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;AtriCure Inc (ATRC) &#8211; Product Pipeline Analysis, 2025 Update&#8221; company profile has been added to ResearchAndMarkets.com&#8217;s offering. This report is a source for data, analysis, and actionable intelligence on the company&#8217;s portfolio of pipeline products. The report provides key information about the company, its major products and brands. AtriCure Inc (AtriCure) is a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-01T18:02:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251231905966\/en\/2680151\/22\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2026-01-01T18:02:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\\\/\"},\"wordCount\":769,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251231905966\\\/en\\\/2680151\\\/22\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\\\/\",\"name\":\"AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251231905966\\\/en\\\/2680151\\\/22\\\/logo.jpg\",\"datePublished\":\"2026-01-01T18:02:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251231905966\\\/en\\\/2680151\\\/22\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251231905966\\\/en\\\/2680151\\\/22\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;AtriCure Inc (ATRC) &#8211; Product Pipeline Analysis, 2025 Update&#8221; company profile has been added to ResearchAndMarkets.com&#8217;s offering. This report is a source for data, analysis, and actionable intelligence on the company&#8217;s portfolio of pipeline products. The report provides key information about the company, its major products and brands. AtriCure Inc (AtriCure) is a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2026-01-01T18:02:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251231905966\/en\/2680151\/22\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies &#8211; ResearchAndMarkets.com","datePublished":"2026-01-01T18:02:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/"},"wordCount":769,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251231905966\/en\/2680151\/22\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/","name":"AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251231905966\/en\/2680151\/22\/logo.jpg","datePublished":"2026-01-01T18:02:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251231905966\/en\/2680151\/22\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251231905966\/en\/2680151\/22\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/atricure-inc-atrc-product-pipeline-analysis-report-2025-portfolio-led-by-isolator-synergy-atriclip-hybrid-af-therapy-and-cryoice-cryosphere-technologies-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62430"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62430\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}